Serum metabolites in non-alcoholic fatty-liver disease development or reversion; a targeted metabolomic approach within the PREDIMED trial

Serum metabolites in non-alcoholic fatty-liver disease development or reversion; a targeted metabolomic approach within the PREDIMED trial

Abstract Background Limited prospective studies have examined changes in non-alcoholic fatty-liver disease (NAFLD) related serum-metabolites and none the effects of NAFLD-reversion. We aimed to evaluate whether perturbations in metabolites indicate predisposition to NAFLD development and to assess t...

Full description

Bibliographic Details
Main Authors: Christopher Papandreou, Mònica Bullò, Francisco José Tinahones, Miguel Ángel Martínez-González, Dolores Corella, Georgios A. Fragkiadakis, José López-Miranda, Ramon Estruch, Montserrat Fitó, Jordi Salas-Salvadó
Format: Article
Language:English
Published: BMC 2017-09-01
Series:Nutrition & Metabolism
Subjects:
Non-alcoholic fatty liver disease
Metabolomics
Fatty acid metabolism
Hepatic lipotoxicity
Online Access:http://link.springer.com/article/10.1186/s12986-017-0213-3

Internet

http://link.springer.com/article/10.1186/s12986-017-0213-3

Similar Items